Provided by Tiger Trade Technology Pte. Ltd.

Korro Bio, Inc.

10.75
-0.3100-2.80%
Post-market: 10.54-0.2100-1.95%18:03 EDT
Volume:180.78K
Turnover:1.95M
Market Cap:155.04M
PE:-0.86
High:11.09
Open:11.02
Low:10.48
Close:11.06
52wk High:55.89
52wk Low:5.20
Shares:14.42M
Float Shares:10.20M
Volume Ratio:0.43
T/O Rate:1.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.4806
EPS(LYR):-12.4806
ROE:-110.70%
ROA:-32.14%
PB:3.01
PE(LYR):-0.86

Loading ...

Korro Bio Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
Nov 13, 2025

Korro Bio Inc : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $11 From $180

THOMSON REUTERS
·
Nov 13, 2025

Korro Bio Inc : Raymond James Cuts to Market Perform From Strong Buy

THOMSON REUTERS
·
Nov 13, 2025

Korro Bio's Pivot to GaINac Pragmatic After 'Disappointing' KRRO-110 Data, RBC Says

MT Newswires Live
·
Nov 13, 2025

RBC Downgrades Korro Bio to Sector Perform From Outperform, Slashes Price Target to $8 From $85, Keeps Speculative Risk

MT Newswires Live
·
Nov 13, 2025

Korro Bio Shares Drop 78.5% Premarket After Experimental Drug Krro-110 Fails in Trial, Pauses Novo Nordisk Deal

THOMSON REUTERS
·
Nov 13, 2025

Korro Bio Inc : RBC Cuts to Sector Perform From Outperorm; Cuts Target Price to $8 From $85

THOMSON REUTERS
·
Nov 13, 2025

Korro Bio Inc : H.c. Wainwright Cuts to Neutral Rating

THOMSON REUTERS
·
Nov 13, 2025

U.S. RESEARCH ROUNDUP-Abbvie, BristolMyers Squibb, Diversified Healthcare

Reuters
·
Nov 13, 2025

Korro Bio Inc : Chardan Capital Markets Cuts to Neutral From Buy; Cuts Target Price to $7 From $25

THOMSON REUTERS
·
Nov 13, 2025

Korro Bio downgraded to Neutral from Overweight at Cantor Fitzgerald

TIPRANKS
·
Nov 13, 2025

Korro Bio downgraded to Hold from Buy at Clear Street

TIPRANKS
·
Nov 13, 2025

This biotech is halting its work with Novo Nordisk and laying off more people

Dow Jones
·
Nov 13, 2025

BUZZ-Korro Bio plunges on trial failure, Novo Nordisk deal halt

Reuters
·
Nov 13, 2025

Korro Bio Inc - Co & Novo Nordisk Pause Agreement for 12 Months - SEC Filing

THOMSON REUTERS
·
Nov 13, 2025

Korro Bio- Effective Nov 11, Co & Novo Nordisk Amend Collaboration Agreement - SEC Filing

THOMSON REUTERS
·
Nov 13, 2025

Korro Bio-Novo Nordisk Agreed to Reimburse Korro for Certain Wind-Down Costs Associated With Hold Period

THOMSON REUTERS
·
Nov 13, 2025

Korro Bio Inc -Agreed to Wind-Down Its Research and Development Activities in Connection With the License Agreement

THOMSON REUTERS
·
Nov 13, 2025

Korro Bio to Cut 34% of Jobs After Pausing Novo Nordisk Deal

Dow Jones
·
Nov 13, 2025

Korro Bio Q3 EPS $(1.92) Beats $(2.59) Estimate, Sales $1.090M Beat $578.222K Estimate

Benzinga
·
Nov 13, 2025